Junping Hong

The Ohio State University — United States

Medicine · Health Sciences

14h-index676citations33works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(9), Viral-associated cancers and disorders(9), Cytomegalovirus and herpesvirus research(7), COVID-19 Clinical Research Studies(6), Herpesvirus Infections and Treatments(6)

Publications33 total

Driving Forces for Synergistic Reduction of Carbon Dioxide Emissions and Ozone Pollution in Chinese Cities
Health and Metabolism·2026Open Access
A Chimeric Virus-Like Particle Vaccine Presenting an Immunodominant Epitope of gB Elicited Potent Neutralizing Antibodies against EBV Infection <i>In Vitro</i> and <i>In Vivo</i>
ACS Applied Materials & Interfaces·2025· 1 cited
Minimax Bayesian Neural Networks
Entropy·2025· 2 citedOpen Access
Research progress on neutralizing antibodies against Epstein-Barr virus glycoproteins
Scientia Sinica Vitae·2024Open Access
Plasmonic Nanograin Metasurface with Disorder‐Enhanced Biosensing for SARS‐CoV‐2 Variant and Antibodies
Advanced Functional Materials·2024· 5 cited
Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine
npj Vaccines·2024· 7 citedOpen Access
Correction: The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors
Journal of Experimental & Clinical Cancer Research·2023· 1 citedOpen Access
Bayesian Neural Networks: A Min-Max Game Framework
arXiv (Cornell University)·2023Open Access
Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infection
Cell Reports Medicine·2023· 15 citedOpen Access
The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors
Journal of Experimental & Clinical Cancer Research·2023· 10 citedOpen Access
Neutralizing antibodies against EBV gp42 show potent <i>in vivo</i> protection and define novel epitopes
Emerging Microbes & Infections·2023· 16 citedOpen Access
Determination of the synergistic anti-influenza effect of Huangqin Su tablet and Oseltamivir and investigation of mechanism of the tablet based on gut microbiota and network pharmacology
BMC Complementary Medicine and Therapies·2023· 6 citedOpen Access
Affinity Exploration of SARS-CoV-2 RBD Variants to mAb-Functionalized Plasmonic Metasurfaces for Label-Free Immunoassay Boosting
ACS Nano·2023· 39 cited
Multivariate Time Series Forecasting With GARCH Models on Graphs
IEEE Transactions on Signal and Information Processing over Networks·2023· 17 cited
Urgency and necessity of Epstein-Barr virus prophylactic vaccines
npj Vaccines·2022· 75 citedOpen Access
A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus
Virology Journal·2022· 3 citedOpen Access
Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation
Vaccine·2022· 16 citedOpen Access
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion
Proceedings of the National Academy of Sciences·2022· 55 citedOpen Access
Glycoprotein B Antibodies Completely Neutralize EBV Infection of B Cells
Frontiers in Immunology·2022· 21 citedOpen Access
A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2
Science Bulletin·2022· 120 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Yixin Chen(25), Ningshao Xia(19), Qian Wu(13), L. Zhong(10), Qingbing Zheng(9), Wanlin Zhang(9), Guosong Wang(8), Quan Yuan(8), Tianying Zhang(8), Miao Xu(8), Jian Ma(7), Jun Zhang(7), Qinjian Zhao(7), Mu‐Sheng Zeng(7), Yi‐Xin Zeng(7), Lunzhi Yuan(6), Rirong Chen(6), Ruoyao Qi(6), Qiangyuan Han(6), Tong Cheng(6)